Shanghai Fudan-zhangjiang Bio-pharmaceutical Co., Ltd.
Clinical trials sponsored by Shanghai Fudan-zhangjiang Bio-pharmaceutical Co., Ltd., explained in plain language.
-
New cancer drug enters first human trials
Disease control Recruiting nowThis is the first time researchers are testing the experimental drug FZ-AD004 in people. The study aims to find a safe and tolerable dose for patients with advanced solid tumors that have spread or cannot be surgically removed. Researchers will also gather early information on wh…
Phase: PHASE1 • Sponsor: Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New light treatment tested for fading birthmarks
Disease control Recruiting nowThis study is testing a light-based treatment called photodynamic therapy to reduce the appearance of port-wine birthmarks. It will enroll 84 adults to compare different light doses and a placebo treatment. The main goals are to see if the treatment is safe and how well it works …
Phase: PHASE2 • Sponsor: Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC
-
First patients receive experimental cancer drug in new trial
Disease control Recruiting nowThis is the first study in people to test a new drug called FZ-AD005. The main goals are to find a safe dose and see how the body processes the drug. Researchers will also look for early signs that it might help shrink tumors in patients with advanced cancers, particularly certai…
Phase: PHASE1 • Sponsor: Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Mar 09, 2026 14:25 UTC